8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Apr 16, 2026·SEC
Material company update
Feb 4, 2026·SEC
LifeVantage Corporation(LFVN)Earnings, Financials & Key Ratios
LFVN•NASDAQ
8.4× P/E·Price updated Jun 19, 2026
AboutLifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.Show more
- Revenue$229M+14.2%
- EBITDA$15M+94.0%
- Net Income$10M+233.8%
- EPS (Diluted)0.76+230.4%
- Gross Margin80.37%+1.4%
- EBITDA Margin6.72%+70.0%
- Operating Margin5.34%+146.7%
- Net Margin4.29%+192.4%
- ROE32.34%+233.9%
LFVN Key Insights
LifeVantage Corporation (LFVN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Good 3Y average ROE of 16.6%
- ✓Healthy dividend yield of 2.5%
- ✓Efficient asset utilization: 3.2x turnover
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when LFVN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
LFVN Price & Volume
LifeVantage Corporation (LFVN) stock price & volume — 10-year historical chart
Loading chart...
LFVN Growth Metrics
LifeVantage Corporation (LFVN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years1.85%
5 Years-0.38%
3 Years3.46%
TTM-12.15%
Profit CAGR
10 Years3.45%
5 Years-3.22%
3 Years46.48%
TTM-37.14%
EPS CAGR
10 Years4.49%
5 Years-0.77%
3 Years46.85%
TTM-34.54%
Return on Capital
10 Years32.29%
5 Years20.95%
3 Years16.35%
Last Year29.49%
LFVN Recent Earnings
LifeVantage Corporation (LFVN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (45%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.12-25.0%
$0.16
Rev
$44M-8.5%
$48M
Q1 2026
Feb 4, 2026Metric
Actual
Est
EPS
$0.15-21.1%
$0.19
Rev
$49M-10.1%
$54M
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.18+5.9%
$0.17
Rev
$58M+7.4%
$54M
Q4 2025
Sep 4, 2025Metric
Actual
Est
EPS
$0.17+0.0%
$0.17
Rev
$55M-4.9%
$58M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.12vs $0.16-25.0% | $44Mvs $48M-8.5% |
| Q1 2026 | Feb 4, 2026 | $0.15vs $0.19-21.1% | $49Mvs $54M-10.1% |
| Q4 2025 | Nov 4, 2025 | $0.18vs $0.17+5.9% | $58Mvs $54M+7.4% |
| Q4 2025 | Sep 4, 2025 | $0.17vs $0.17+0.0% | $55Mvs $58M-4.9% |
Based on last 12 quarters of dataView full earnings history →
LFVN Peer Comparison
LifeVantage Corporation (LFVN) competitors in Nutrition and functional foods — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NATR | 353.81M | 20.12 | 18.98 | 5.67% | 4.06% | 12.08% | 0.12 | |
 NHTC | 20.31M | 1.82 | -23.73 | -7.42% | -3.03% | -4.88% | 0.13 | |
 QNST | 750.24M | 13.06 | 161.83 | 78.27% | 5.53% | 23.85% | 0.04 | |
 HLF | 1.23B | 11.90 | 5.41 | 0.89% | 4.67% | |||
 USNA | 348.47M | 18.88 | 32.55 | 8.28% | 1.16% | 1.84% | 0.02 | |
 NUS | 243.72M | 5.02 | 1.58 | -14.26% | 3.78% | 6.84% | 0.45 | |
 PLBY | 135.38M | 1.45 | -11.15 | 4.13% | -6.21% | -79.7% | 10.81 | |
 MGIC | 853.35M | 17.38 | 23.17 | 3.26% | 6.64% | 13.38% | 0.29 |
Compare LFVN vs Peers
LifeVantage Corporation (LFVN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LFVN Income Statement
LifeVantage Corporation (LFVN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 199.49M | 203.2M | 225.96M | 232.91M | 220.18M | 206.36M | 213.4M | 200.16M | 228.53M | 195.32M |
Revenue Growth % | -3.41% | 1.86% | 11.2% | 3.08% | -5.47% | -6.28% | 3.41% | -6.2% | 14.17% | -12.15% |
Cost of Goods Sold | 33.46M | 34.85M | 37.97M | 37.96M | 38.19M | 38.1M | 43.39M | 41.44M | 44.86M | 42.7M |
COGS % of Revenue | 16.77% | 17.15% | 16.81% | 16.3% | 17.34% | 18.46% | 20.33% | 20.7% | 19.63% | - |
Gross Profit | 166.03M▲ 0% | 168.36M▲ 1.4% | 187.99M▲ 11.7% | 194.95M▲ 3.7% | 181.99M▼ 6.6% | 168.26M▼ 7.5% | 170.01M▲ 1.0% | 158.72M▼ 6.6% | 183.67M▲ 15.7% | 152.62M▲ 0% |
Gross Margin % | 83.23% | 82.85% | 83.19% | 83.7% | 82.66% | 81.54% | 79.67% | 79.3% | 80.37% | 78.14% |
Gross Profit Growth % | -3.81% | 1.4% | 11.66% | 3.71% | -6.65% | -7.54% | 1.04% | -6.64% | 15.71% | - |
Operating Expenses | 161.58M | 158.03M | 178.17M | 179.49M | 164.38M | 160.69M | 165.75M | 154.39M | 171.47M | 136.87M |
OpEx % of Revenue | 81% | 77.77% | 78.85% | 77.06% | 74.66% | 77.87% | 77.67% | 77.13% | 75.03% | - |
Selling, General & Admin | 161.58M | 158.03M | 178.17M | 179.49M | 164.38M | 63.42M | 71.06M | 68.47M | 69.21M | 63.22M |
SG&A % of Revenue | 81% | 77.77% | 78.85% | 77.06% | 74.66% | 30.74% | 33.3% | 34.21% | 30.28% | - |
Research & Development | 1.1M | 1.2M | 1.1M | 0 | 700K | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | 0.55% | 0.59% | 0.49% | - | 0.32% | - | - | - | - | - |
Other Operating Expenses | -969K | -319K | -261K | 0 | -700K | 97.26M | 94.69M | 85.92M | 102.26M | 4M |
Operating Income | 4.45M▲ 0% | 10.32M▲ 132.0% | 9.49M▼ 8.1% | 15.47M▲ 63.0% | 17.61M▲ 13.9% | 7.58M▼ 57.0% | 4.26M▼ 43.8% | 4.33M▲ 1.7% | 12.2M▲ 181.6% | 6.58M▲ 0% |
Operating Margin % | 2.23% | 5.08% | 4.2% | 6.64% | 8% | 3.67% | 2% | 2.16% | 5.34% | 3.37% |
Operating Income Growth % | -66.83% | 132.03% | -8.06% | 62.95% | 13.89% | -57% | -43.78% | 1.71% | 181.6% | - |
EBITDA | 6.09M | 11.65M | 11.39M | 20.57M | 21.07M | 10.84M | 7.84M | 7.91M | 15.36M | 8.69M |
EBITDA Margin % | 3.05% | 5.73% | 5.04% | 8.83% | 9.57% | 5.25% | 3.67% | 3.95% | 6.72% | 4.45% |
EBITDA Growth % | -60.21% | 91.2% | -2.25% | 80.63% | 2.48% | -48.58% | -27.67% | 0.96% | 94.05% | -46.25% |
D&A (Non-Cash Add-back) | 1.64M | 1.32M | 1.9M | 5.1M | 3.46M | 3.26M | 3.58M | 3.58M | 3.16M | 2.11M |
EBIT | 3.48M | 10M | 9.55M | 14.78M | 17.61M | 4.7M | 4.26M | 4.33M | 12.2M | 4.9M |
Net Interest Income | -570K | -456K | -323K | -120K | -17K | -10K | 198K | 430K | 431K | 218K |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 198K | 430K | 431K | 218K |
Interest Expense | 570K | 456K | 323K | 120K | 17K | 10K | 0 | 0 | 0 | 0 |
Other Income/Expense | -1.54M | -775K | -584K | -805K | -383K | -2.88M | -260K | 18K | 44K | 185K |
Pretax Income | 2.91M▲ 0% | 9.55M▲ 228.1% | 9.23M▼ 3.3% | 14.66M▲ 58.8% | 17.23M▲ 17.5% | 4.69M▼ 72.8% | 4M▼ 14.8% | 4.35M▲ 8.8% | 12.24M▲ 181.4% | 6.77M▲ 0% |
Pretax Margin % | 1.46% | 4.7% | 4.08% | 6.29% | 7.83% | 2.27% | 1.87% | 2.17% | 5.36% | 3.46% |
Income Tax | 1.3M | 3.79M | 1.8M | 3.11M | 4.34M | 1.57M | 1.46M | 1.41M | 2.44M | 426K |
Effective Tax Rate % | 44.74% | 39.66% | 19.51% | 21.23% | 25.17% | 33.49% | 36.48% | 32.48% | 19.91% | 6.3% |
Net Income | 1.61M▲ 0% | 5.76M▲ 258.3% | 7.43M▲ 29.0% | 11.55M▲ 55.5% | 12.89M▲ 11.6% | 3.12M▼ 75.8% | 2.54M▼ 18.6% | 2.94M▲ 15.6% | 9.8M▲ 233.8% | 5.75M▲ 0% |
Net Margin % | 0.81% | 2.84% | 3.29% | 4.96% | 5.86% | 1.51% | 1.19% | 1.47% | 4.29% | 2.94% |
Net Income Growth % | -73.28% | 258.27% | 28.95% | 55.46% | 11.65% | -75.8% | -18.59% | 15.63% | 233.84% | -37.14% |
Net Income (Continuing) | 1.61M | 5.76M | 7.43M | 11.55M | 12.89M | 3.12M | 2.54M | 2.94M | 9.8M | 5.75M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.11▲ 0% | 0.41▲ 272.7% | 0.50▲ 22.0% | 0.79▲ 58.0% | 0.90▲ 13.9% | 0.24▼ 73.3% | 0.20▼ 16.7% | 0.23▲ 15.0% | 0.76▲ 230.4% | 0.45▲ 0% |
EPS Growth % | -73.17% | 272.73% | 21.95% | 58% | 13.92% | -73.33% | -16.67% | 15% | 230.43% | -34.54% |
EPS (Basic) | 0.12 | 0.41 | 0.53 | 0.82 | 0.92 | 0.24 | 0.20 | 0.24 | 0.80 | - |
Diluted Shares Outstanding | 14.12M | 14.14M | 14.98M | 14.6M | 14.27M | 13.07M | 12.57M | 12.99M | 12.99M | 12.66M |
Basic Shares Outstanding | 13.88M | 13.99M | 14.05M | 14.11M | 14.07M | 12.89M | 12.56M | 12.46M | 12.25M | 12.63M |
Dividend Payout Ratio | - | - | - | - | 2.93% | 12.12% | 62.44% | 236.3% | 21.08% | - |
LFVN Balance Sheet
LifeVantage Corporation (LFVN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 35.55M | 38.94M | 43.19M | 43.87M | 48.05M | 46.96M | 44.28M | 37.65M | 50.89M | 39.31M |
Cash & Short-Term Investments | 11.46M | 16.65M | 18.82M | 22.14M | 23.17M | 20.19M | 21.61M | 16.89M | 20.2M | 12.48M |
Cash Only | 11.46M | 16.65M | 18.82M | 22.14M | 23.17M | 20.19M | 21.61M | 16.89M | 20.2M | 12.48M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 2.25M | 2.52M | 3.3M | 2.61M | 3.96M | 5.09M | 1.85M | 3.26M | 3.93M | 2.42M |
Days Sales Outstanding | 4.11 | 4.52 | 5.33 | 4.09 | 6.57 | 9 | 3.17 | 5.95 | 6.28 | 8.04 |
Inventory | 16.57M | 13.63M | 13.75M | 13.89M | 16.14M | 16.47M | 16.07M | 15.05M | 20.67M | 18.38M |
Days Inventory Outstanding | 180.83 | 142.73 | 132.2 | 133.52 | 154.32 | 157.82 | 135.22 | 132.6 | 168.16 | 161.16 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 4.75M | 2.44M | 6.09M | 6.03M |
Total Non-Current Assets | 9.7M | 12.2M | 12.09M | 15.01M | 30.68M | 23.75M | 21.84M | 22.65M | 21.06M | 22.81M |
Property, Plant & Equipment | 3.13M | 6.59M | 7.13M | 8.13M | 24.82M | 20.54M | 17.82M | 17.38M | 14.25M | 13.76M |
Fixed Asset Turnover | 63.80x | 30.85x | 31.69x | 28.66x | 8.87x | 10.05x | 11.97x | 11.52x | 16.04x | 13.67x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 472K |
Intangible Assets | 1.25M | 1.11M | 983K | 851K | 719K | 587K | 455K | 323K | 245K | 3.19M |
Long-Term Investments | 0 | 0 | 0 | 2.21M | 2.21M | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 1.24M | 1.25M | 1.28M | 1.66M | 1.72M | 1.33M | 569K | 680K | 601K | 591K |
Total Assets | 45.25M▲ 0% | 51.14M▲ 13.0% | 55.27M▲ 8.1% | 58.88M▲ 6.5% | 78.73M▲ 33.7% | 70.71M▼ 10.2% | 66.12M▼ 6.5% | 60.3M▼ 8.8% | 71.96M▲ 19.3% | 62.13M▲ 0% |
Asset Turnover | 4.41x | 3.97x | 4.09x | 3.96x | 2.80x | 2.92x | 3.23x | 3.32x | 3.18x | 3.08x |
Asset Growth % | -9.97% | 13.02% | 8.08% | 6.52% | 33.72% | -10.19% | -6.48% | -8.81% | 19.34% | 4.03% |
Total Current Liabilities | 23.36M | 23.8M | 26.2M | 25.02M | 25.2M | 25.73M | 19.61M | 22.31M | 27.22M | 20.1M |
Accounts Payable | 4.85M | 3.81M | 5.18M | 4.61M | 7.59M | 7.92M | 4.22M | 6.29M | 5.06M | 5.15M |
Days Payables Outstanding | 52.91 | 39.94 | 49.79 | 44.33 | 72.56 | 75.91 | 35.54 | 55.38 | 41.16 | 43.06 |
Short-Term Debt | 2M | 2M | 1.45M | 0 | 0 | 0 | 0 | 0 | 0 | 1.89M |
Deferred Revenue (Current) | 1.74M | 1.11M | 998K | 792K | 319K | 78K | 834K | 860K | 711K | 0 |
Other Current Liabilities | 12.2M | 11.52M | 1.06M | 4.55M | 1.5M | 971K | 3.1M | 1.61M | 5.33M | 13.07M |
Current Ratio | 1.52x | 1.64x | 1.65x | 1.75x | 1.91x | 1.83x | 2.26x | 1.69x | 1.87x | 1.96x |
Quick Ratio | 0.81x | 1.06x | 1.12x | 1.20x | 1.27x | 1.18x | 1.44x | 1.01x | 1.11x | 1.04x |
Cash Conversion Cycle | 132.03 | 107.32 | 87.74 | 93.28 | 88.33 | 90.91 | 102.84 | 83.18 | 133.27 | 126.14 |
Total Non-Current Liabilities | 7.37M | 5.39M | 1.88M | 604K | 16.73M | 13.46M | 11.87M | 12M | 10.1M | 8.69M |
Long-Term Debt | 5.44M | 3.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.32M |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 16.03M | 13.15M | 11.57M | 11.8M | 9.81M | 28.99M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1.93M | 1.98M | 1.88M | 604K | 694K | 308K | 299K | 198K | 289K | 366K |
Total Liabilities | 30.72M | 29.2M | 28.07M | 25.62M | 41.92M | 39.19M | 31.47M | 34.31M | 37.32M | 28.79M |
Total Debt | 7.44M | 5.41M | 1.45M | 1.18M | 18.18M | 15.76M | 13.09M | 13.61M | 11.68M | 10.21M |
Net Debt | -4.02M | -11.24M | -17.37M | -20.95M | -4.99M | -4.43M | -8.52M | -3.27M | -8.52M | -2.28M |
Debt / Equity | 0.51x | 0.25x | 0.05x | 0.04x | 0.49x | 0.50x | 0.38x | 0.52x | 0.34x | 0.31x |
Debt / EBITDA | 1.22x | 0.46x | 0.13x | 0.06x | 0.86x | 1.45x | 1.67x | 1.72x | 0.76x | 1.17x |
Net Debt / EBITDA | -0.66x | -0.96x | -1.53x | -1.02x | -0.24x | -0.41x | -1.09x | -0.41x | -0.56x | -0.26x |
Interest Coverage | 6.11x | 21.94x | 29.58x | 123.18x | 1036.18x | 470.10x | - | - | - | - |
Total Equity | 14.53M▲ 0% | 21.95M▲ 51.1% | 27.2M▲ 23.9% | 33.25M▲ 22.3% | 36.81M▲ 10.7% | 31.52M▼ 14.4% | 34.65M▲ 9.9% | 25.99M▼ 25.0% | 34.64M▲ 33.3% | 33.34M▲ 0% |
Equity Growth % | 19.75% | 51.08% | 23.93% | 22.26% | 10.68% | -14.37% | 9.94% | -24.99% | 33.28% | 65.35% |
Book Value per Share | 1.03 | 1.55 | 1.82 | 2.28 | 2.58 | 2.41 | 2.76 | 2.00 | 2.67 | 2.63 |
Total Shareholders' Equity | 14.53M | 21.95M | 27.2M | 33.25M | 36.81M | 31.52M | 34.65M | 25.99M | 34.64M | 33.34M |
Common Stock | 14K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
Retained Earnings | -106.99M | -102.73M | -99.96M | -93.31M | -92.35M | -98.44M | -98.31M | -108.74M | -104.15M | -103.66M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -94K | 14K | 62K | 144K | 104K | -1.12M | -1.36M | -1.92M | -1.18M | -1.73M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LFVN Cash Flow Statement
LifeVantage Corporation (LFVN) cash flow — operating, investing & free cash flow history
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 6.6M | 13.26M | 17.79M | 18.33M | 7.96M | 7.96M | 6.83M | 12.2M | 11.88M | 6.51M |
Operating CF Margin % | 3.31% | 6.52% | 7.87% | 7.87% | 3.61% | 3.86% | 3.2% | 6.09% | 5.2% | - |
Operating CF Growth % | 9.29% | 100.94% | 34.2% | 3.02% | -56.57% | 0% | -14.21% | 78.63% | -2.62% | -301.1% |
Net Income | 1.61M | 5.76M | 7.43M | 11.55M | 3.12M | 3.12M | 2.54M | 2.94M | 9.8M | 5.75M |
Depreciation & Amortization | 1.64M | 1.32M | 1.9M | 5.1M | 3.26M | 3.26M | 3.58M | 3.58M | 3.16M | 2.83M |
Stock-Based Compensation | 2.65M | 3.2M | 5.53M | 4.92M | 1.77M | 1.77M | 3.19M | 3.28M | 5.7M | 2.92M |
Deferred Taxes | -740K | 831K | 563K | 364K | -81K | -81K | -1.7M | -1.28M | -1.7M | 2.13M |
Other Non-Cash Items | 381K | 32K | 42K | 46K | 3.99M | 3.99M | 1.78M | 1.3M | 1.47M | 4.4M |
Working Capital Changes | 1.06M | 2.11M | 2.33M | -3.65M | -4.1M | -4.1M | -2.56M | 2.38M | -6.55M | -11.52M |
Change in Receivables | -752K | -268K | -771K | 698K | -1.33M | -1.33M | 3.07M | -1.5M | -564K | -1.41M |
Change in Inventory | 8.31M | 2.95M | -64K | -152K | -1.19M | -1.19M | 61K | 662K | -5.22M | 1.74M |
Change in Payables | -6.21M | -1.02M | 1.37M | -1.65M | 824K | 824K | -3.98M | 2.3M | -1.29M | -1.89M |
Cash from Investing | -1.05M | -4.65M | -4.51M | -2.68M | -1.53M | -1.53M | -3.06M | -2.25M | -1.37M | -6.48M |
Capital Expenditures | -1.05M | -4.65M | -2.51M | -2.68M | -1.53M | -1.53M | -3.07M | -2.25M | -1.37M | -2.73M |
CapEx % of Revenue | 0.53% | 2.29% | 1.11% | 1.15% | 0.69% | 0.74% | 1.44% | 1.12% | 0.6% | 1.4% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | -2M | 0 | 0 | 0 | 8K | 0 | 4K | -3.74M |
Cash from Financing | -1.96M | -3.5M | -11.12M | -12.42M | -8.95M | -8.95M | -2.36M | -14.42M | -7.6M | -9.88M |
Debt Issued (Net) | -2M | -2M | -4M | -1.5M | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 0 | -1.5M | -7.82M | -11.65M | -9.08M | -8.57M | -771K | -7.38M | -5.53M | -9.5M |
Dividends Paid | 0 | 0 | 0 | 0 | -378K | -378K | -1.59M | -6.94M | -2.07M | -2.28M |
Share Repurchases | 0 | -1.5M | -7.82M | -11.65M | -9.08M | -9.08M | -1.02M | -7.65M | -5.81M | -9.73M |
Other Financing | 42K | 1K | 701K | 729K | 505K | 0 | 0 | -97K | 0 | 1.9M |
Net Change in Cash | 3.58M▲ 0% | 5.19M▲ 45.3% | 2.17M▼ 58.2% | 3.31M▲ 52.6% | -2.98M▼ 190.0% | -2.98M▲ 0.0% | 1.42M▲ 147.4% | -4.72M▼ 433.5% | 3.31M▲ 170.2% | -9.99M▲ 0% |
Free Cash Flow | 5.54M▲ 0% | 8.61M▲ 55.3% | 15.28M▲ 77.6% | 15.64M▲ 2.4% | 6.43M▼ 58.9% | 6.43M▲ 0.0% | 3.76M▼ 41.5% | 9.95M▲ 164.6% | 10.51M▲ 5.6% | 3.77M▲ 0% |
FCF Margin % | 2.78% | 4.24% | 6.76% | 6.72% | 2.92% | 3.12% | 1.76% | 4.97% | 4.6% | 1.93% |
FCF Growth % | 1.24% | 55.3% | 77.56% | 2.37% | -58.91% | 0% | -41.5% | 164.61% | 5.58% | -68.48% |
FCF per Share | 0.39 | 0.61 | 1.02 | 1.07 | 0.45 | 0.49 | 0.30 | 0.77 | 0.81 | 0.30 |
FCF Conversion (FCF/Net Income) | 4.10x | 2.30x | 2.39x | 1.59x | 0.62x | 2.55x | 2.69x | 4.15x | 1.21x | 0.66x |
Interest Paid | 438K | 345K | 227K | 44K | 0 | 0 | 5K | 21K | 2K | 9K |
Taxes Paid | 5.5M | 2.87M | 1.29M | 1.62M | 0 | 0 | 1.87M | 2.31M | 4.92M | 2.2M |
LFVN Key Ratios
LifeVantage Corporation (LFVN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 12.06% | 31.59% | 30.23% | 38.21% | 36.81% | 9.13% | 7.68% | 9.69% | 32.34% | 17.78% |
Return on Invested Capital (ROIC) | 27.62% | 72.98% | 69.32% | 104.84% | 59.89% | 19.29% | 12.01% | 13.3% | 37.47% | 16.89% |
Gross Margin | 83.23% | 82.85% | 83.19% | 83.7% | 82.66% | 81.54% | 79.67% | 79.3% | 80.37% | 78.14% |
Net Margin | 0.81% | 2.84% | 3.29% | 4.96% | 5.86% | 1.51% | 1.19% | 1.47% | 4.29% | 2.94% |
Debt / Equity | 0.51x | 0.25x | 0.05x | 0.04x | 0.49x | 0.50x | 0.38x | 0.52x | 0.34x | 0.31x |
Interest Coverage | 6.11x | 21.94x | 29.58x | 123.18x | 1036.18x | 470.10x | - | - | - | - |
FCF Conversion | 4.10x | 2.30x | 2.39x | 1.59x | 0.62x | 2.55x | 2.69x | 4.15x | 1.21x | 0.66x |
Revenue Growth | -3.41% | 1.86% | 11.2% | 3.08% | -5.47% | -6.28% | 3.41% | -6.2% | 14.17% | -12.15% |
Related:LFVN Dividend History·LFVN Revenue History·LFVN Price History·LFVN P/E History·LFVN Financial Ratios·LFVN Institutional Holders
LFVN SEC Filings & Documents
LifeVantage Corporation (LFVN) SEC filings — annual & quarterly reports (10-K, 10-Q)
LFVN Frequently Asked Questions
LifeVantage Corporation (LFVN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
LifeVantage Corporation (LFVN) reported $195.3M in revenue for fiscal year 2025.
LifeVantage Corporation (LFVN) grew revenue by 14.2% over the past year. This is steady growth.
Yes, LifeVantage Corporation (LFVN) is profitable, generating $5.8M in net income for fiscal year 2025 (4.3% net margin).
Dividend & Returns
Yes, LifeVantage Corporation (LFVN) pays a dividend with a yield of 2.48%. This makes it attractive for income-focused investors.
LifeVantage Corporation (LFVN) has a return on equity (ROE) of 32.3%. This is excellent, indicating efficient use of shareholder capital.
LifeVantage Corporation (LFVN) generated $3.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.